Membrane damage and repair in primary monocytes exposed to human β-defensin-3

Anthony B Lioi1, Angel L Reyes Rodriguez, Nicholas T Funderburg

  • 1Department of Molecular Biology and Microbiology, Division of Infectious Diseases, Center for AIDS Research, Case Western Reserve University, Cleveland, OH 44106, USA.

Insights

Human immune cells, like monocytes, show varying susceptibility to antimicrobial peptides (AMPs). Negatively charged phospholipids on monocyte membranes contribute to their vulnerability to hBD-3, impacting therapeutic applications.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Interactions between antimicrobial peptides (AMPs) and human immune cell plasma membranes are not well understood.
  • Understanding these interactions is crucial for evaluating AMPs as potential human therapeutics.

Purpose of the Study:

  • To investigate the differential susceptibility of human immune cells (monocytes, T cells, B cells) to the antimicrobial peptide human beta-defensin 3 (hBD-3).
  • To elucidate the membrane-related mechanisms underlying monocyte sensitivity to hBD-3.

Main Methods:

  • Analysis of propidium iodide (PI) exclusion to assess membrane integrity.
  • Microscopic observation of bleb formation and LAMP1 expression as a membrane repair marker.
  • Assessment of cellular cholesterol content via filipin staining.
  • Investigation of phosphatidylserine (PS) exposure and its role in hBD-3 susceptibility.

Main Results:

  • hBD-3 caused membrane perturbations and bleb formation in monocytes, but not T or B cells, at relevant concentrations.
  • Monocytes exhibited increased LAMP1 expression and enhanced cell death upon hBD-3 exposure, particularly when membrane repair was inhibited.
  • Outer membrane phosphatidylserine (PS) exposure in monocytes was identified as a key factor contributing to their increased susceptibility to hBD-3-induced membrane damage.

Conclusions:

  • Monocytes are more susceptible to hBD-3-induced membrane damage than T or B cells, partly due to higher surface expression of negatively charged PS.
  • The findings highlight the importance of evaluating AMP-induced membrane disruption across diverse human immune cell types for therapeutic development.
  • Targeting or understanding PS exposure could be critical for the safe and effective use of AMPs in human therapies.

Related Concept Videos